NASDAQ · Biotechnology

IMA (IMA) Stock

$5.69 +1.07% NASDAQ: IMA Healthcare

Valuation

MetricValue
Price$5.69
Market Cap$64.18M
P/E Ratio-1.49
P/B Ratio0.54
P/S Ratio66.55
EPS (TTM)$-3.37
52-Week High$18.00
52-Week Low$3.94
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-86.15%
ROA-45.62%
ROCE-36.09%
Gross Margin-4800.00%
Operating Margin-4800.00%
Net Margin-4500.00%
Debt/Equity0.07
Current Ratio12.73

Annual Financials (USD)

Metric20212022202320242025
Revenue$31.0M$16.0M$9.0M$4.0M$1.0M
Operating Profit$-34.0M$-71.0M$-75.0M$-37.0M$-48.0M
Net Profit$-34.0M$-69.0M$-68.0M$-37.0M$-45.0M
EPS$-0.95$-1.90$-1.63$-1.02$-10.76
Op Margin-110.2%-454.0%-823.3%-1057.1%-6056.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$248.0M$172.0M$192.0M$142.0M$153.0M
Total Liabilities$40.0M$25.0M$22.0M$16.0M$20.0M
Cash$232.0M$60.0M$120.0M$39.0M$35.0M
Borrowings$7.0M$6.0M$11.0M$8.0M$10.0M

Latest News

ImageneBio Appoints Matt Robbins as General Counsel GlobeNewswire · Jul 7, 2026 ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York GlobeNewswire · May 27, 2026 ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update GlobeNewswire · May 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-60.0M$-74.0M$-80.0M$-46.0M$-48.0M
Investing Cash Flow$-4.0M$-101.0M$64.0M$-35.0M$-6.0M
Financing Cash Flow$1.0M$1.0M$38.0M$0$55.0M
Net Cash Flow$70.0M$-172.0M$60.0M$-81.0M$82.0M
Free Cash Flow$-62.0M$-76.0M$-80.0M$-46.0M$-48.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA0.95
FCF Yield-78.26%
Quick Ratio18.39
Interest Coverage—
Return 1Y-63.38%
Return 3Y-91.79%
Return 5Y-95.68%

Ownership

Insiders Held11.26%
Institutions Held48.16%
Institutions Float Held54.27%
Institutional HolderSharesReport Date
BVF Inc.1,110,0022026-03-31
Blue Owl Capital Holdings LP959,3372026-03-31
Orbimed Advisors LLC.909,2692026-03-31
Cable Car Capital, LP754,7492026-03-31
Omega Fund Management, Llc455,3612026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARTV $11.27 -2.68% -2.29 $278.56M 0.00%
CNTB $2.07 -1.67% -2.31 $130.02M 0.00%
CNTX $0.62 +4.47% -6.84 $56.69M 0.00%
IFRX $1.84 +6.98% -4.16 $132.91M 0.00%
KLRS $3.40 +1.80% -2.86 $63.59M 0.00%

About IMA

IMA is led by CEO Kristin Yarema, employs 10 people, headquartered in US, publicly traded since 1998.

IMA stock trades at $5.69 with a market capitalization of $64.18M. The stock is valued at a price-to-earnings (P/E) ratio of -1.49, price-to-book of 0.54, price-to-sales of 66.55. Over the past 52 weeks the stock has ranged between $3.94 and $18.00, and currently trades 68.4% below its 52-week high.

On profitability, IMA generates a return on equity (ROE) of -86.15%, return on capital employed of -36.09%, an operating margin of -4800.00%, a net profit margin of -4500.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides